How long can you live if brain cancer metastasizes

Brain cancer is a general term for intracranial malignant tumors and the entire malignant tumor. If the tumor is small, there will be no obvious symptoms in the early stage. Epilepsy and headaches occasionally occur in patients. As the disease progresses, intracranial pressure increases significantly, and the patient's headache and dizziness symptoms become significantly aggravated, accompanied by nausea, vomiting, and functional impairment. Depending on the location of the tumor, the clinical symptoms may also be different. Frontal lobe patients may have obvious psychiatric symptoms. Parietal lobe patients will experience limb hemiplegia; temporal lobe patients may experience epilepsy and language disorders.

Brain cancer is a type of tumor. For patients with brain cancer, we recommend early detection and early treatment. For brain cancer, we first look at its stage, including the type of tumor. If it is a malignant brain cancer patient, please try to recommend more care and understanding at home. The survival of brain cancer patients depends on the size of the brain tumor, including the size of the tumor, the location of the tumor, and whether surgery is possible. However, the malignancy of general brain cancer is relatively high, so the relative survival period will not be too long.

Brain cancer is actually not quite correct, because intracranial tumors are usually divided into neuroepithelial tumors and meningiomas. These tumors all come from mesenchymal tissue, so they are often called tumors, not cancer. If it is a benign intracranial tumor, including primary neuroepithelial tumors and meningiomas, a normal human life cycle can be achieved after complete surgical resection. If it is a secondary neuroepithelial tumor, that is, a glioma, if it can be completely removed and then combined with radiation therapy, it is basically the same as a normal human life cycle. Grade 3 and 4 gliomas have a poor prognosis, usually no more than 2 to 3 years.

The survival of brain cancer patients mainly depends on the pathological type of the primary disease, the location of the tumor, the extent of surgical resection, and subsequent treatment. In general, the most common primary malignant tumors and glioblastomas in the brain, while intracranial metastatic malignant tumors depend on the intracranial side on the one hand. On the other hand, the control of the primary lesion depends on the control of systemic metastasis. The specific survival of the patient needs to be determined according to the clinical situation. With the existing treatment methods, the patient's survival can be significantly prolonged and should be actively treated in neurosurgery.